David Chien Lye

Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine

National University of Singapore (NUS) - Department of Microbiology and Immunology

5 Science Drive 2 Blk MD4, Level 3

117545

Singapore

  • National University of Singapore (NUS) - Department of Microbiology and Immunology

SCHOLARLY PAPERS

13

DOWNLOADS
Rank 14,770

SSRN RANKINGS

Top 14,770

in Total Papers Downloads

7,058

TOTAL CITATIONS

50

Scholarly Papers (13)

Actions:
Email selected abstracts
1.

Clinical and Virological Features of SARS-CoV-2 Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta)

Number of pages: 24 Posted: 07 Jun 2021
Sean Wei Xiang Ong, Calvin J. Chiew, Li Wei Ang, Tze-Minn Mak, Lin Cui, Matthias Paul HS Toh, Yi Ding Lim, Pei Hua Lee, Tau Hong Lee, Po Ying Chia, Sebastian Maurer-Stroh, Raymond Tzer Pin Lin, Yee-Sin Leo, Vernon J. Lee, David Chien Lye and Barnaby E. Young
National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore, Ministry of Health, Singapore, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore, Agency for Science, Technology and Research (A*STAR) - Bioinformatics Institute, National Centre for Infectious Diseases, National University of Singapore (NUS) - Department of Microbiology and Immunology, Ministry of Health, Singapore, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine and National Centre for Infectious Diseases, Singapore
Downloads 6,199 (2,715)
Citation 41

Abstract:

Loading...

COVID-19; SARS-CoV-2; B.1.1.7; B.1.351; B.1.617; variants of concern; severity; mortality

2.

Antibody Response of Heterologous vs Homologous mRNA Vaccine Boosters Against the SARS-CoV-2 Omicron Variant: Interim Results from the PRIBIVAC Study, A Randomized Clinical Trial

Number of pages: 35 Posted: 16 Mar 2022
Xuan Ying Poh, Chee Wah Tan, I. Russel Lee, Jean-Marc Chavatte, Siew‐Wai Fong, Tessa Prince, Catherine Hartley, Aileen Ying-Yan Yeoh, Suma Rao, Po Ying Chia, Sean Wei Xiang Ong, Tau Hong Lee, Sapna P. Sadarangani, Ray JH Lin, Clarissa Lim, Jefanie Teo, Daniel WX Lim, Wanni Chia, Julian A. Hiscox, Lisa F.P. Ng, Ee Chee Ren, Raymond Tzer Pin Lin, Laurent Renia, David Chien Lye, Lin Fa Wang and Barnaby E. Young
National Centre for Infectious Diseases, Duke NUS Medical School, National Centre for Infectious Diseases, National Centre for Infectious Diseases, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, University of Liverpool, University of Liverpool, Duke-NUS Medical School, National Centre for Infectious Diseases, National Centre for Infectious Diseases, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, National Centre for Infectious Diseases, National Centre for Infectious Diseases, National Centre for Infectious Diseases, National Centre for Infectious Diseases, Duke-NUS Medical School, University of Liverpool, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, National University of Singapore (NUS), National Centre for Infectious Diseases, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, Duke-NUS Medical School - Programme in Emerging Infectious Diseases and National Centre for Infectious Diseases, Singapore
Downloads 203 (317,906)
Citation 5

Abstract:

Loading...

COVID-19 vaccine booster, humoral immunity, omicron, live virus neutralization

3.

Long-Term Neurological and Psychiatric Sequelae in COVID-19 Survivors after Omicron BA.1/2 and Delta Infection: A Retrospective Cohort Study in Singapore

Number of pages: 19 Posted: 31 Jul 2023
Liang En Wee, Jue Tao Lim, An Ting Tay, Deanette Pang, Borame Sue Lee Dickens, Calvin J. Chiew, Benjamin Ong, David Chien Lye and Kelvin Bryan Tan
National Centre for Infectious Diseases, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, Ministry of Health, Singapore, Ministry of Health, Singapore, National University of Singapore (NUS) - Saw Swee Hock School of Public Health, National Centre for Infectious Diseases, Singapore, Ministry of Health, Singapore, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine and Ministry of Health, Singapore
Downloads 106 (544,021)

Abstract:

Loading...

SARS-CoV-2, COVID-19, Neurology, Psychiatry, Omicron, Delta

4.

Comparison of the Clinical Features, Viral Shedding and Immune Response in Vaccine Breakthrough Infection by the Omicron and Delta Variants

Number of pages: 35 Posted: 24 Jun 2022
Sai Meng Tham, Siew‐Wai Fong, Zi-Wei Chang, Kai Sen Tan, Angeline Rouers, Yun Shan Goh, Douglas Jie Wen Tay, Sean Wei Xiang Ong, Ying Hao, Siang Li Chua, Jean-Marc Chavatte, Lin Cui, Matthew Zirui Tay, Raymond Tzer Pin Lin, Laurent Renia, Yee-Sin Leo, Justin Jang Hann Chu, David Chien Lye, Lisa F.P. Ng, Barnaby E. Young and PROTECT Cohort Study Group
National University of Singapore (NUS) - National University Hospital, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, National University of Singapore (NUS) - Department of Microbiology and Immunology, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, National University of Singapore (NUS) - Department of Microbiology and Immunology, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, National Centre for Infectious Diseases, National Centre for Infectious Diseases, National Centre for Infectious Diseases, Singapore, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, National Centre for Infectious Diseases, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, National University of Singapore (NUS) - Department of Microbiology and Immunology, National University of Singapore (NUS) - Department of Microbiology and Immunology, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, National Centre for Infectious Diseases, Singapore and Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs
Downloads 99 (571,245)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Delta, Omicron, variants of concern, vaccine breakthrough

5.

Real-World Effectiveness of Sotrovimab and Remdesivir for Early Treatment of High-Risk Hospitalized COVID-19 Patients

Number of pages: 20 Posted: 08 Jul 2022
Lin Pin Koh, Siang Li Chua, Shawn Vasoo, Matthias Paul HS Toh, Jeremy Nicholas Cutter, Puay Hoon Nah, Yee-Sin Leo, Jun Xin Tay, Barnaby E. Young, David Chien Lye and Sean Wei Xiang Ong
National Centre for Infectious Diseases, National Centre for Infectious Diseases, National Centre for Infectious Diseases, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, National Centre for Infectious Diseases, National University of Singapore (NUS) - Department of Microbiology and Immunology, National Centre for Infectious Diseases, National Centre for Infectious Diseases, Singapore, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine and National Centre for Infectious Diseases
Downloads 95 (586,731)

Abstract:

Loading...

COVID-19, SARS-CoV-2, early-treatment, sotrovimab, remdesivir, high-risk

6.

Prolonged Inflammation in COVID-19 Survivors Resolves 2 Years After Coronavirus Disease 2019 (COVID-19)

Number of pages: 48 Posted: 27 Jun 2022
Siew‐Wai Fong, Yun Shan Goh, Anthony Torres-Ruesta, Zi Wei Chang, Yi-Hao Chan, Vanessa Kexin Neo, Bernett Lee, Kaibo Duan, Siti Naqiah Amrun, Nicholas Kim‐Wah Yeo, Matthew Zirui Tay, Guillaume Carissimo, COVID-19 Study Group, NCID Study Group, Seow-Yen Tan, Yee-Sin Leo, David Chien Lye, Laurent Renia, Barnaby E. Young and Lisa F.P. Ng
Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Independent, Independent, Changi General Hospital - Department of Infectious Diseases, National University of Singapore (NUS) - Department of Microbiology and Immunology, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, National Centre for Infectious Diseases, Singapore and Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs
Downloads 82 (641,990)

Abstract:

Loading...

Long COVID, inflammation, subclinical signs, COVID vaccine

7.

Respiratory Syncytial Virus Hospitalization Costs, Rates, and Seasonality in Asia: A Systematic Review and Meta-Analysis

Number of pages: 37 Posted: 06 Feb 2025
Darren Sim Junfeng, Luis J. Ponce, Jo Yi Chow, Ian L.E. Wee, Po Ying Chia, David Chien Lye, Yee-Sin Leo and Jue Tao Lim
Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, National University of Singapore (NUS) - Singapore General Hospital, National Centre for Infectious Diseases, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, National University of Singapore (NUS) - Department of Microbiology and Immunology and Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine
Downloads 77 (665,543)

Abstract:

Loading...

Respiratory Syncytial Virus, Systematic Review and Meta-Analysis, RSV Incidence, RSV Seasonality, Hospitalization Costs, Public Health Burden, Asia, Low- and Middle-Income Countries

8.

Association of SARS-CoV-2 Clades with Clinical, Inflammatory and Virologic Outcomes: An Observational Study

Number of pages: 33 Posted: 05 Jan 2021
Barnaby E. Young, Wycliffe E. Wei, Siew-Wai Fong, Tze-Minn Mak, Danielle E. Anderson, Yi-Hao Chan, Rachael Pung, Cheryl SY Heng, Li Wei Ang, Kang Eng Zheng, Bernett Lee, Shirin Kalimuddin, Surinder Pada, Paul A. Tambyah, Purnima Parthasarathy, Seow-Yen Tan, Louisa Sun, Gavin JD Smith, Raymond Tzer Pin Lin, Yee-Sin Leo, Laurent Renia, Lin-Fa Wang, Lisa F.P. Ng, Sebastian Maurer-Stroh, David Chien Lye and Vernon J. Lee
National Centre for Infectious Diseases, Singapore, National Public Health and Epidemiology Unit, National Centre for Infectious Diseases, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases, Singapore, Duke NUS Medical School, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Government of the Republic of Singapore - Communicable Diseases Division, Ministry of Health, Singapore, National Centre for Infectious Diseases, Singapore, Duke NUS Medical School, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National University of Singapore (NUS) - Department of Infectious Diseases, Ng Teng Fong General Hospital - Division of Infectious Diseases, National University Health System, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Khoo Teck Puat Hospital, Changi General Hospital - Department of Infectious Diseases, Alexandra Hospital, Duke-NUS Medical School, National Centre for Infectious Diseases, National University of Singapore (NUS) - Department of Microbiology and Immunology, Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Duke NUS Medical School, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Bioinformatics Institute, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine and Ministry of Health, Singapore
Downloads 58 (772,799)

Abstract:

Loading...

9.

BNT162b2 Antenatal Vaccination for Each Pregnancy Needed to Maintain Protection of Infants Against Omicron

Number of pages: 17 Posted: 25 Jul 2023
Orlanda Q. Goh, Deanette Pang, Janice Tan, David Chien Lye, Chia Yin Chong, Benjamin Ong, Kelvin Bryan Tan and Chee Fu Yung
National University of Singapore (NUS) - Policy and Research Division, Ministry of Health, Singapore, Ministry of Health, Singapore, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, KK Women's and Children's Hospital, Ministry of Health, Singapore, Ministry of Health, Singapore and Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine
Downloads 47 (853,481)

Abstract:

Loading...

SARS-CoV-2, maternal vaccination, Omicron, XBB variant, infants

10.

Immune Landscape of 382-Nt Deleted SARS-CoV-2 Reveals Heightened Adaptive Response Indicating Prophylactic Potential Against COVID-19

Number of pages: 90 Posted: 21 Oct 2020
Siew-Wai Fong, Nicholas Kim-Wah Yeo, Yi-Hao Chan, Yun Shan Goh, Siti Naqiah Amrun, Nicholas Ang, Josephine Lum, Shihui Foo, Cheryl Yi-Pin Lee, Guillaume Carissimo, Rhonda Sin-Ling Chee, Anthony Torres-Ruesta, Matthew Zirui Tay, Zi Wei Chang, Chek Meng Poh, Barnaby E. Young, Paul A. Tambyah, Shirin Kalimuddin, Yee-Sin Leo, David Chien Lye, Bernett Lee, Subhra Biswas, Shanshan W. Howland, Laurent Renia and Lisa F.P. Ng
Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, National University of Singapore (NUS) - Department of Infectious Diseases, National University of Singapore (NUS) - Department of Microbiology and Immunology, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN) and Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN)
Downloads 34 (972,859)

Abstract:

Loading...

COVID-19, SARS-CoV-2, transcriptome, ORF8, deletion, RNA-seq

11.

SARS-CoV-2 Infection Generates Long-Lived Memory B Cells Against the Receptor Binding Domain of the Spike Protein

Number of pages: 41 Posted: 14 Dec 2021
Angeline Rouers, Matthew Zirui Tay, Siew‐Wai Fong, Yun Shan Goh, Zi Wei Chang, Siti Naqiah Amrun, Nicholas Kim‐Wah Yeo, Yuling Huang, Pei Xiang Hor, Chiew Yee Loh, Yi-Hao Chan, Guillaume Carissimo, Jackwee Lim, Weili Xu, Kaibo Duan, Menaka P. Rajapakse, Bei Wang, Eve Ngoh, Chia Yin Lee, Siti Nazihah Mohd Salleh, Paul A. MacAry, Cheng-I Wang, Bernett Lee, Olaf Rotzschke, Seow-Yen Tan, Barnaby E. Young, Yee-Sin Leo, David Chien Lye, Lisa F.P. Ng and Laurent Renia
Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National University of Singapore (NUS) - Department of Microbiology and Immunology, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Changi General Hospital - Department of Infectious Diseases, National Centre for Infectious Diseases, Singapore, National University of Singapore (NUS) - Department of Microbiology and Immunology, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs and Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs
Downloads 24 (1,085,443)

Abstract:

Loading...

antibodies, memory B cells, SARS-COV-2, COVID-19, severity, RBD, spike protein, long-lived

12.

Sensitive Detection of Total Anti-Spike Antibodies and Isotype Switching in Asymptomatic and Symptomatic COVID-19 Patients

Number of pages: 44 Posted: 23 Oct 2020
Yun Shan Goh, Jean-Marc Chavatte, Alicia Lim Jieling, Bernett Lee, Siti Naqiah Amrun, Cheryl Yi-Pin Lee, Rhonda Sin-Ling Chee, Bei Wang, Chia Yin Lee, Eve Ngoh, Cheng-I Wang, Barnaby E. Young, Paul A. Tambyah, Shirin Kalimuddin, Surinder Pada, Seow-Yen Tan, Louisa Sun, Mark I-Cheng Chen, Yee-Sin Leo, David Chien Lye, Lisa F.P. Ng, Raymond Tzer Pin Lin and Laurent Renia
Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, National Centre for Infectious Diseases, National Centre for Infectious Diseases, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, National University of Singapore (NUS) - Department of Infectious Diseases, Ng Teng Fong General Hospital - Division of Infectious Diseases, Changi General Hospital - Department of Infectious Diseases, Alexandra Hospital, National Centre for Infectious Diseases, National University of Singapore (NUS) - Department of Microbiology and Immunology, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases and Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre
Downloads 21 (1,122,824)
Citation 2

Abstract:

Loading...

SARS-CoV-2, COVID-19, serological, S protein, antibodies, IgG subclasses, symptomatic, asymptomatic

13.

Omicron Reactive Multi Protein Specific CD4 T Cells Defines Cellular Immune Response Induced by Inactivated Virus Vaccines

Number of pages: 50 Posted: 02 Jun 2022
Joey Lim, Shou Kit Hang, Smrithi Hariharaputran, Adeline Chia, Nicole Tan, Eng Sing Lee, Edwin Chng, Poh Lian Lim, Barnaby E. Young, David Chien Lye, Nina Le Bert, Antonio Bertoletti and Anthony T. Tan
National University of Singapore (NUS) - Program in Emerging Infectious Diseases, National University of Singapore (NUS) - Program in Emerging Infectious Diseases, National University of Singapore (NUS) - Program in Emerging Infectious Diseases, National University of Singapore (NUS) - Program in Emerging Infectious Diseases, National University of Singapore (NUS) - Program in Emerging Infectious Diseases, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, affiliation not provided to SSRN, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, National Centre for Infectious Diseases, Singapore, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, Duke-NUS Medical School - Program in Emerging Infectious Diseases, Duke-NUS Medical School - Program in Emerging Infectious Diseases and Duke-NUS Medical School - Program in Emerging Infectious Diseases
Downloads 13 (1,221,480)
Citation 2

Abstract:

Loading...

COVID-19, inactivated vaccine, mRNA vaccine, T cell response, adaptive immune response